| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $457.5M | +12.7% |
| Cost of Revenue | $102.7M | +12.3% |
| Gross Profit | $354.9M | +12.9% |
| R&D Expense | $101.3M | -1.5% |
| SG&A Expense | $106.5M | +21.2% |
| Operating Income | -$43.5M | +28.0% |
| Interest Expense | $2.5M | -29.0% |
| Pre-tax Income | -$42.7M | +30.3% |
| Income Tax | $587K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $95.3M | +10.2% |
| Accounts Receivable | $101.0M | +20.2% |
| Current Assets | $237.2M | +12.8% |
| Total Assets | $523.1M | +22.1% |
| Current Liabilities | $256.3M | +16.1% |
| Long-term Debt | $40.0M | +60.0% |
| Total Liabilities | $319.6M | +22.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $43.4M | +65.0% |
| Capital Expenditures | $4.1M | +39.2% |
| Investing Cash Flow | -$52.1M | -228.0% |
| Financing Cash Flow | $15.5M | +151.1% |
| Free Cash Flow | $39.3M | +68.2% |
| -12.4% |
| Net Income | -$43.3M | +30.1% |
| EPS (Diluted) | -$0.74 | +32.1% |
| Stockholders' Equity |
| $203.4M |
| +22.1% |